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Knowledge  production  and  scientific  research  have  become  increasingly  more  collaborative  and  inter-
national,  particularly  in pharmaceuticals.  We  analyze  this  tendency  in  general  and  tie  formation  in
international  research  networks  on  the  country  level  in particular.  Based  on  a unique  dataset  of  scientific
publications  related  to pharmaceutical  research  and  applying  social  network  analysis,  we  find  that  both
the number  of countries  and  their  connectivity  increase  in  almost  all disease  group  specific  networks.
The  cores  of the  networks  consist  of  high  income  OECD  countries  and  remain  rather  stable  over  time.
Using  network  regression  techniques  to analyze  the  network  dynamics  our  results  indicate  that  accum-
ulative  advantages  based  on  connectedness  and  multi-connectivity  are  positively  related  to  changes  ineywords:
nternational cooperation
harmaceuticals
esearch networks
etwork dynamics
the countries’  collaboration  intensity  whereas  various  indicators  on  similarity  between  countries  do  not
allow for  unambiguous  conclusions.
© 2013 Elsevier B.V. All rights reserved.RQAP
. Introduction
Collaboration between different actors has become an increas-
ngly more important mode of knowledge generation in almost all
cientific disciplines (Wuchty et al., 2007). Particularly in science-
ased fields and research areas with rapidly developing and widely
istributed knowledge bases, no single actor has the ability to keep
ace with the scientific and technological advances in all areas. Con-
equently, increasing collaboration within collaboration networks
ave been found to be a means by which actors can pool, exchange
nd develop ideas, knowledge and other resources (Powell and
rodal, 2005; Powell et al., 1996; Powell and Brantley, 1992). In this
aper we are interested in the dynamics of collaboration networks
n general and tie formation herein in particular.
We  pursue our analysis for pharmaceuticals, where innova-
ion is based on scientific advances and thus clearly connected to
asic and applied research (Lim, 2004). Pharmaceutical innovation
an be seen the result of interaction and collaboration between a
road set of different types of agents endowed with complementary
∗ Corresponding author. Tel.: +49 851 509 2483.
E-mail addresses: uwe.cantner@uni-jena.de (U. Cantner),
astian.rake@uni-passau.de (B. Rake).
048-7333/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.respol.2013.10.016knowledge, competencies and other resources (e.g. Pisano, 1991;
Orsenigo, 1989). Since this field is characterized by a complex,
expanding and dispersed knowledge base, the locus of innovation,
and thus the appropriate level of analysis, is no longer the individual
actor, but rather the entire network (Powell et al., 1996). Its struc-
ture and the actors’ positions therein determine the actors’ access
to relevant sources of knowledge and may  therefore have conse-
quences for their innovative activities and performance (Powell
et al., 1999; Walker et al., 1997; Kogut et al., 1994).
Against this background of a specific research area, pharmaceut-
icals, and following the analytical design of Wagner and Leydesdorff
(2005a), we  pursue an analysis on the country level, implying that
the collaborating actors within the network are countries. Our devi-
ation from an analysis on the level of individual actors is justified
by the presumption that for the dynamics of international col-
laboration networks in pharmaceutical research the country level
embraces an additional and important influence on the formation
of and the changes in those networks. Looking at the research
and collaboration activities in pharmaceuticals worldwide as mea-
sured by publications and co-authored publications we,  first, find
the OECD countries to be the main actors in both categories. Sec-
ondly, these countries show a continuous reinforcement of the
co-authorship ties among each other over time combined with
a slightly but steadily increasing widening out of collaborative
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ctivities to other countries. For OECD countries this, third, is
videnced by a growth of the number of internationally col-
aborated publications exceeding the growth of the number of
on-collaborated ones: their growth rates of the number of inter-
ationally collaborated publications are about 37% which is almost
wice as high as their growth rates of non-collaborated publica-
ions. Fourth, for non-OECD countries, starting from a much lower
umber of publications, the growth rates of publications are much
igher, between 60% and 95%, with only a minor difference between
he growth of the number internationally collaborated and non-
ollaborated publications for this group.1 This, fifth, leads to a
hare of collaborative in all publications which increases for OECD
ountries from almost 17% to 22% and which remains nearly sta-
le for non-OECD countries between 20% and 21%. Taken these five
bservations for worldwide research in pharmaceuticals together,
ECD countries are dominant in these activities, show a higher
nclination for, and put more emphasis on international scientific
ollaboration. Hence, from a research network perspective, OECD
ountries tend to be at the core of those networks and should be
onsidered the main drivers of network dynamics. We  consider
hese patterns as an indication for country level factors having a
rominent effect on the structure and dynamics of the international
harmaceutical research network.
Among the country level factors, in our context, the national
nnovative capacity matters most. It is considered as the bind-
ng frame for research as well as innovation activities and their
ery structures influence the long-term ability of a country to gen-
rate and commercialize innovative technologies (Furman et al.,
002). Countries differ in their national innovative capacity. Hence,
he exchange of knowledge and approaches for problem solving
mong organizations embedded in national contexts with country-
pecific scientific and technological advantages can be seen as a
river for international collaborations (Bartholomew, 1997; Shan
nd Hamilton, 1991; Dosi et al., 1990). Although the national inno-
ation systems are connected among each other, the development
f the pharmaceutical industry in general and the development of
he related research networks in particular are closely connected
o the structure of national institutions (Henderson et al., 1999).
ifferences in the national institutional setting and the national
nnovative capacity may  at least partly explain the considerable
ifferences of research activities in different disease groups on the
ountry level (cf. Furman et al., 2006).
International scientific collaboration between countries can be
een as a self-organizing network as suggested in Wagner and
eydesdorff (2005a). The position of each country within the net-
ork is determined by economic, social, political, and cultural
actors. These factors include the priorities of scientists and policy
akers to conduct research in particular fields and to collaborate
ith different partners (Miquel and Okubo, 1994). They can be
onsidered as part of the national innovative capacity of a coun-
ry that influences by itself scientific collaboration in lower order
ubsystems, such as pharmaceuticals, and induces the dynamics
f the cross-country network. These subsystems contribute to the
ynamics on the international level while they are at the same time
ffected by the dynamics on the international level (Wagner and
eydesdorff, 2005a). Within this analytical context, we  explore the
tructure and the dynamics of international research collaboration
etworks for different disease groups in pharmaceutical research.
We use social network analysis to investigate collaboration
etworks and to calculate network statistics for different disease
1 This trend is prevalent for the comparison of all three sub-periods analyzed in
his  study, 1998–2000, 2002–2004, and 2006–2008. We obtain qualitatively similar
esults if we  look at the biggest contributors in the number of publications in the
ample instead of OECD countries.olicy 43 (2014) 333– 348
groups. Moreover, we analyze endogenous network dynamics, i.e.
mechanisms within the network that are responsible for new con-
nections being build up or existing ones being cut off. Therefore,
we test whether the connectedness of countries, the similarity of
countries or their degree of multi-connectivity are the driving fac-
tors of tie formation within the networks. In order to investigate
the network dynamics, we draw upon multiple regression analysis
for dyadic data (Butts and Carley, 2001; Krackhardt, 1988). More
precisely, we apply the multiple regression quadratic assignment
procedure (MRQAP) with double semi-partialing (DSP) as proposed
by Dekker et al. (2007), which is particularly robust against multi-
collinearity and network-autocorrelation.
Our empirical analysis is performed on a unique dataset of pub-
lications in scientific journals related to pharmaceutical research.
We  analyze three periods, 1998–2000, 2002–2004, and 2006–2008.
A first inspection reveals that high income OECD countries are
located in the center of the network in all periods and disease
areas. Although often connected to countries in the core, only a few
non-OECD countries have managed to become part of the center
of the international research community. Our descriptive network
statistics indicate increasing cross-county collaboration in almost
all disease groups.
Our regression results reveal that dyadic tie formation and
break-up is positively related to the amount of previous collabo-
ration. This finding may  indicate an accumulative advantage based
on the degree of connectedness of a country in a network. We do
not find a clear-cut association between differences in the visibil-
ity of two countries, as another proxy for connectedness, and the
change in the number of research collaborations. Moreover, sim-
ilarity of two countries in terms of income groups and language
has no unambiguous association with the changes in the number of
collaborations. Country differences in the strength of their research
sectors are negatively related to the change of their bilateral collab-
orations. Multi-connectivity, in terms of other countries connecting
two countries, is positively related to changes in the number of
collaborations between them, whereas we  find a negative asso-
ciation for the number of shortest paths between two countries.
From a policy perspective, our results suggest that supporting inter-
national research collaborations and investments strengthening
countries’ scientific systems may  help countries located at periph-
eral positions in the network to get access to the relevant sources
of knowledge and to overcome liabilities of unconnectedness.
The remainder of the paper is structured as follows: Section 2
presents related literature on research networks and its dynamics.
In Section 3, we  present the methods and the data used in this paper.
Descriptive network statistics can be found in Section 4. Results of
our regression analysis are presented in Section 5. Finally, Section 6
concludes.
2. Related literature
2.1. Internationalization of research networks
Research and innovation activities worldwide appear to be per-
formed more and more in collaboration. With respect to scientific
collaboration, there is a large body of evidence for an increasing
amount of co-authored research. This trend towards scientific col-
laboration has been found in a broad set of disciplines and across
different periods (Wuchty et al., 2007; Wagner-Döbler, 2001; de
Solla Price, 1963). These studies suggest that the interconnected-
ness of authors and institutions has considerably increased during
the last decades. This growth in scientific collaboration activities
is not bound within national boundaries but shows an interna-
tional outreach. As Adams et al. (2005) show, on a large sample
of publications originating in U.S research universities, the rate of
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ational collaborations more than doubled and the rate of inter-
ational collaborations increased five-fold from the 1980s to the
ate 1990s. These results are in line with other studies pointing
ut the increasing amount of international scientific collaboration
n Europe (e.g. Mattsson et al., 2008; Frenken, 2002; Okubo and
jöberg, 2000). Increasing collaboration has not only been observed
n science, but also with respect to R&D and innovative activities
n general. Hagedoorn (2002) finds an increasing number of R&D
lliances since the 1980s that can be found in a diverse set of indus-
ries, such as the computer, semiconductor, chemical and footwear
ndustries (e.g. Boschma and ter Wal, 2007; Ahuja, 2000; Saxenian,
991). Moreover, also collaborative R&D activities show an increas-
ng level of internationalization (Guellec and van Pottelsberghe de
a Potterie, 2001; Granstrand, 1999).
A prominent case in terms of collaboration in science and
nnovation is the pharmaceutical industry. In this industry the
&D process is based on a diverse set of knowledge from var-
ous scientific disciplines. The rapid growth of an increasingly
odified and abstract knowledge base (Gambardella, 1995; Arora
nd Gambardella, 1994) and its dispersion among a broad vari-
ty of actors induced a pronounced trend towards collaboration
nd network formation (Powell et al., 2005; McKelvey et al., 2004).
rganizations (including established pharmaceutical companies,
iotechnology firms, universities, public research institutes, and
enture capitalists) with complementary resources and competen-
ies are involved in the networks of collaborative relations and
nnovations are the ultimate outcome of their interaction and col-
aboration (e.g. Pisano, 1991; Orsenigo, 1989). Numerous studies
ave described and visualized the growth of R&D partnerships
etween these different types of organizations (e.g. Roijakkers and
agedoorn, 2006; Powell et al., 2005). The complementarity of
ssets and key competencies of biotechnology firms and pharma-
eutical companies has been found to be an important driver of the
rowth of R&D partnerships on the organizational level (e.g. Senker
nd Sharp, 1997). The international dimension of collaboration
n the pharmaceutical industry is particularly pronounced when
iotechnological knowledge is involved and regionally clustered
rganizations extent their collaboration beyond national borders
Cooke, 2006). This tendency is reinforced by the fact that biotech-
ology and pharmaceutical companies locate R&D facilities outside
heir home countries, connect to a considerable number of inter-
ational research partners, and source knowledge on a global scale
Tijssen, 2009; Gassmann and von Zedtwitz, 1999). Publication
ata reflects these observations. In almost one quarter of corpo-
ate research publications, institutions from at least three world
egions are involved (Calero et al., 2007).
The observed increasing internationalization of collaborative
ctivities in scientific research and innovation has certainly its
rigin in the collaboration decisions of the cooperating organi-
ations. Above and beyond that, however, there appears to be a
ather aggregated dimension involved, the level of countries. Look-
ng at co-publication activities in science in general reveals an
xpansion in the number of involved countries and the connec-
ions among them (Wagner and Leydesdorff, 2005a). However, not
ll countries are connected to the core, and some are grouped
n otherwise disconnected clusters. Over time, the global scien-
ific network has become less centralized, with new regional hubs
merging (Wagner and Leydesdorff, 2005a). With respect to R&D
ollaborations in general, the majority of alliances worldwide are
eographically concentrated among North America, Europe, Japan,
nd South Korea (Hagedoorn, 2002).
For the pharmaceutical industry a similar pattern of interna-
ionalization emerges which seems to be even more pronounced,
articularly with respect to scientific collaboration (Calero et al.,
007). U.S. based companies, universities, and public research orga-
izations have been dominating the industry since the emergenceolicy 43 (2014) 333– 348 335
of biotechnology in the 1970s. Hence, linkages to the U.S. have
been important means for European organizations to increase their
capabilities and competitiveness (Sharp and Senker, 1999). An anal-
ysis of international R&D projects based on patent data reveals the
central role of U.S. based organizations for connecting pharmaceu-
tical research originating in different countries (Owen-Smith et al.,
2002).
Based on this literature and evidence, we  are interested in the
international dimension of research networks and we analyze them
in terms of connections between countries. Quite generally, a net-
work in an economic sense is composed of heterogeneous actors,
in our case countries, the relationships among them and other
contextual features that affect actors’ behavior and decisions, as
well as the generation and application of knowledge. Concerning
actors involved quite generally, they have different knowledge and
competencies, different rules of action, and different incentives
and motivations. They are linked to one another through a web
of different relationships, including formal links, e.g. contractual
cooperation agreements, as well as less formal relationships, such
as joint membership in a community of practice or a regional econ-
omy, and all kinds of “intermediate relations” (Powell and Grodal,
2005; McKelvey et al., 2004).
In this paper, we follow Wagner and Leydesdorff (2005a) and
refer to countries as actors in the networks we  analyze. The
edges between the countries represent co-authorship relationships
between authors located different countries. The “behavior” of a
country within a network reflects an “aggregate behavior” which is
determined by economic, social, political and cultural factors. These
factors include the priorities of scientists, organizations, and policy
makers to conduct research in particular fields and to collaborate
with different international partners (Miquel and Okubo, 1994). In
this sense the “aggregate behavior” we  refer to is considered as
being quite closely related to the national innovative capacity of
a country. Certainly, we  cannot observe an “aggregate behavior”
directly, but we consider a country’s pattern of co-authorship rela-
tions being the outcome of an “aggregate behavior” and we track
these patterns over time.
2.2. Network dynamics
Based on the increasing importance of international scientific
collaboration, we  analyze changes in collaboration networks over
time. For that we  anchor our analysis onto a theory that draws
on network theory in general and on a theory on the dynam-
ics of networks in particular. Network theory (e.g. Burt, 1992;
Granovetter, 1973) suggests a relational approach to understand
why certain units are connected. It considers the properties of their
relations and hence a comparison (similarities and dissimilarities)
between them as relevant, instead of the properties of the units
itself. Hence, we refer to similarities and dissimilarities of network
units in terms of the properties of ties between them, such as the
number of ties, as well as in terms of relational states and events
that are not directly dyadic, such as economic similarities (Borgatti
and Halgin, 2011).
These elements of network theory are taken over to our
approach on the dynamics of networks (e.g. Ahuja et al., 2012;
Rivera et al., 2010; Powell et al., 2005), and to the related changes
herein. Referring to a notion of change as suggested in evolutionary
economics, we  consider processes that lead to a transformation of
a system from within (Witt, 2008; Schumpeter, 1912). More for-
mally, changes to be observed in t are not independent from past
events or states in t − 1. In the context of collaboration networks,
our evolutionary view implies that the actors’ positions, their con-
nections and their similarities within the network in t influence
the ongoing formation and breaking-up of ties (Kenis and Knoke,
2002).
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The decisions of the formation or breaking up of new ties are
riven by actors’ ambitions to maintain or reconfigure their posi-
ion within the network in order to benefit from opportunities
reated by the network structure (Zaheer and Soda, 2009). In a
cientific co-author network these benefits arise from using, inte-
rating and recombining the knowledge and expertise of another
ctor; the attractiveness of this potential partner depends posi-
ively on his knowledge and expertise as well as on how easy he
an be accessed and understood. Respective kinds and degrees of
his attractiveness will be introduced below.
We  apply our theory of network formation and develop-
ent to the case of inter-country linkages in pharmaceutical
o-publications. Obviously, individual researchers decide on these
ollaborations. Aggregating these researchers and their collabora-
ion decisions on the country level is based on the assumption
hat scientists of the same country behave and decide in a very
uch common way, following Wagner and Leydesdorff (2005a).
hese commonalities can for example be related to country spe-
ific styles and forms of organizing research and science. Our main
uestion in the analysis is on how the network structure in pre-
ious periods affects the interaction structure among countries in
ubsequent periods. We focus on several determinants of this net-
ork dynamics which is mainly driven by changes in the number
f dyadic relationships. In this paper, we concentrate on the dyadic
oncept of connectedness of network actors, on relational states
ndicating similarity of network actors, and multi-connectivity of
etwork actors. We  apply these concepts to analyze and under-
tand the development of cross-country co-author networks in
harmaceutical research.
.2.1. Connectedness
Our first determinant or mechanism driving new tie formation
n t is the connectedness of network actors indicating their attrac-
iveness as potential cooperation partners and given by the total
umber of dyadic relationships a network actor holds in t − 1. This
umber indicates a degree of attractiveness in terms of knowledge
nd expertise others attached to this actor. In relational terms con-
ectedness shows importance for endogenous network formation
Powell et al., 2005) for which we distinguish two  ways. A first
ne is related to a network’s core-periphery structure with highly
onnected core actors on the one hand and low connected periph-
ral actors as well as (in t) not connected new actors on the other.
n those structures dynamics of degree (Rivera et al., 2010) may
ork and in accordance with the Barabási-Albert model (Barabási
nd Albert, 1999). One can expect tie formation in terms of prefer-
ntial attachment based on relative connectedness: New and less
ell-connected actors establish ties preferably to well-connected
ncumbents. Put differently, highly connected core actors in t − 1
re more likely to attract new ties in t. The second way  connected-
ess is related to tie formation in t looks at the number of dyads two
etwork actors hold in common in t − 1 – implying a kind of repeti-
ion dynamics (Rivera et al., 2010). This number of common dyads
vidences the attractiveness of the collaboration between the two
etwork actors. Further tie formation between the two appears to
e positively related to this type of bilateral connectedness.
Both mechanism, via relative connectedness and via bilateral
onnectedness, tracked over time are responsible for a “rich-get-
icher” phenomenon in which network incumbents (early entrants)
ncrease their connectivity at the (relative) expense of newcomers.
 small number of actors shows a high number of ties within the
etwork, whereas the vast majority of actors has relatively few ties.
s a consequence, the distribution of the actor connectivity in real
orld networks frequently follows, at least asymptotically, a scale-
ree power law (Barabási, 2003; Barabási and Albert, 1999).
Empirical analyses on various levels support the conjecture
f connectedness driving new tie formation. The dynamics inolicy 43 (2014) 333– 348
core-periphery structures has been observed for scientific co-
authorship relationships in different disciplines (Wagner and
Leydesdorff, 2005b; Jeong et al., 2003; Newman, 2001). Focusing
on the firm-level, Orsenigo et al. (1998) show that the network
of collaborative R&D agreements in the pharmaceutical industry
(after the emergence of biotechnology) expands by keeping struc-
tural properties rather stable. Especially the non-deformation of
the core-periphery structure and a low propensity to collaborate
among firms of similar age indicate that the number of ties an actor
has established may  have been the driving force in the evolution of
the network (Ter Wal  and Boschma, 2009).
Based on these arguments and evidence we hypothesize that
connectedness is related to changes in the dyadic relationships (tie
formation and break up) also in the cross-country co-author net-
work of pharmaceutical research. First we  explore whether less
well connected countries establish preferably linkages to those
countries that are already well connected within the network. In
this case, the difference in the number of collaborative linkages
to other countries should be related to changes in the number
of collaborations between two countries. We secondly investigate
whether the number of previous dyadic co-author relationships
between two countries is positively related to changes in the ties
between them. We  summarize these conjectures in Hypotheses 1a
and 1b.
Hypothesis 1a. The difference in degree of connectedness (rela-
tive connectedness) between two  countries is positively related to
changes in the number of cross-country co-author collaborations
between them.
Hypothesis 1b. The number of common dyads between two
countries (bilateral connectedness) is positively related to changes
in the number of cross-country co-author collaborations between
them.
2.2.2. Similarity
In most real world networks, the tendency to connect to highly
connected actors is not as high as theoretical models predict. Two
explanations are given. A first one argues that the number of con-
nections an actor can meaningfully maintain is limited. For our
cross-country network based on co-authorships this argument is
difficult to apply or defend. However, a second explanation for-
wards that dimensions other than sheer dyadic connectedness
have to be considered. In this sense, actors are attracted by those
with the highest degree of connectedness, but prefer to connect
to proximate or similar actors (Boschma and Frenken, 2010). This
attractiveness is of a non-dyadic nature and refers to relational
states of actor proximity or similarity.
The theoretical concept behind this reasoning is homophily,
stating that connections are established based on the similarity of
the actors involved (Rivera et al., 2010; McPherson et al., 2001;
Freeman, 1996). Tie formation based on similarities within the
network can be based on restricted opportunities to connect to
dissimilar actors induced by the group to which an actor belongs,
and by preferences to connect to similar partners (McPherson and
Smith-Lovin, 1987). A high level of similarity among the actors of a
(sub)network promotes mutual understanding and thus, influences
the frequency and intensity of communication and interaction as
well as the joint use of knowledge and other resources. Hence,
interaction within homogeneous (sub)networks is subject to a self-
reinforcing process generated within the network (Rogers, 1995).
In order to benefit from the frequent interaction in homogeneous
(sub)networks, the actors build up new ties to actors showing sim-
ilar characteristics.
The relevance of similarity for network formation has found
empirical support on various levels such as on the individual level
in partnering choices (e.g. Bozeman and Corley, 2004; Ruef et al.,
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003; McPherson et al., 2001; McPherson and Smith-Lovin, 1987);
or inter-organizational alliances in German stock photography
rganizational similarity in terms of firm characteristics appear as
 weak explanation (Glückler, 2010) whereas in the biotechnology
ndustry alliance formation is related to similarities in the social
tatus of the management and the role firms play in the industry
Kim and Higgins, 2007).
Related to our country level analysis it has been shown that sim-
larity with respect to the level of economic development, culture,
nd the size and specialization of the national scientific infrastruc-
ure influence the choice of collaboration partners (Zitt et al., 2000;
uukkonen et al., 1992). Since mutual understanding based on eco-
omic, cultural and scientific similarities may  drive the dynamics of
ross-country collaboration we formulate Hypothesis 2 as follows:
ypothesis 2. The degrees of economic, cultural, and scientific
imilarities between two countries are positively related to changes
n the number of cross-country co-author collaborations between
hem.
.2.3. Multi-connectivity
With the concept of connectedness we address a quite narrow
imension of attractiveness based on dyadic relationships and with
imilarity attractiveness is seen in a non-dyadic but rather broad
ense. With our third concept, multi-connectivity, we address the
ndirect relations between actors that potentially will cooperate.
Coleman (1990, 1988) has argued that closely connected
etworks increase cooperation and trust among the actors and thus
nowledge exchange. Hence, the actors in the network have also
ncentives to build up linkages to those actors they are already
ndirectly connected with (Cowan and Jonard, 2007). Building
pon these arguments, Powell et al. (2005) suggest that multi-
onnectivity can be the underlying mechanism that leads to the
mergence of cohesive network structures. Accordingly, actors who
re more diversely linked with each other in t − 1 are more likely
o form a new tie in t than pairs of actors with less diverse indirect
onnections. In this sense, it is multi-connectivity (as measured by
he number of indirect ties between two potential partners) that
rives tie formation – a dynamics of closure and then of clustering
ivera et al. (2010).
The impact of multi-connectivity on tie formation finds empir-
cal evidence in the case of strategic alliances in the German stock
hotography market (Glückler, 2010) and in life sciences between
ifferent types of organizations (Powell et al., 2005). In the former
tudy two actors are more likely to engage in a partnership if they
re connected via third parties and in the latter study this likeli-
ood is higher for actors that are more diversely connected to each
ther in the previous period.
Against this background, we analyze whether multi-
onnectivity is related to the co-authorship dynamics on the
ountry level. In line with the arguments outlined above we  sug-
est a relationship between multi-connectivity and cross-country
ollaboration dynamics as follows:
ypothesis 3. The degree of multi-connectivity between two
ountries is positively related to changes in the number of cross-
ountry co-author collaborations between them.
. Data and research methodology
.1. Social network analysis
Social network analysis has been increasingly applied in eco-
omics to analyze inventor and co-author networks (Cantner and
raf, 2006; Breschi and Catalini, 2010), knowledge spillovers, the
evelopment of technologies (Mina et al., 2007; Verspagen, 2007),
nd the importance of the structure of collaborative relationsolicy 43 (2014) 333– 348 337
for innovative activities (Ahuja, 2000; Baum et al., 2000; Burt,
1992). In our study, we use social network analysis to illustrate
cross-country collaboration patterns in different subfields of phar-
maceutical research. The methodology has been mainly developed
by anthropologists, sociologists and researchers in social psy-
chology, in collaboration with mathematicians, statisticians, and
computer scientists. The concept of social networks is based on the
assumption of the importance of relationships among interacting
units. Beyond this aspect, there are four additional paradigmatic
properties characterizing social network research. Behavior is seen
as interdependent, relational ties are means of resource transfer,
the network structure provides opportunities and constraints for
individual actions, and the network structure illustrates lasting
patterns of relationships (Wasserman and Faust, 1994).
Following these basic characteristics, we can define a network as
a finite set of actors and their relations among one another. Actors
can be defined as discrete individual, corporate, or collective units
(Wasserman and Faust, 1994). In the graphical representation of
a network, actors are represented as nodes or vertices. Since we
aim to analyze cross-country collaboration in the pharmaceutical
industry, we refer to countries as actors in our network. Social ties
represent linkages among actors. In order to establish ties among
countries, we  use co-publications between different organizations
which may  or may  not be located in different countries. The col-
lection of ties, i.e. co-publications, defines the relations among the
different actors or countries. In the graphical representation of the
co-publication network, relations among nodes are expressed by
undirected arcs.
In order to describe the properties of the cross-country collabo-
ration networks in different therapeutic areas, we  compute several
descriptive statistics. The number of countries describes the count
of countries with at least one publication in the respective field. An
important characteristic of a network graph is its connectedness,
analyzed by computing the number of components. It is connected
if there is a path between every pair of nodes. This implies that
all pairs of nodes in the graph can be reached through some path,
regardless of its length. Nodes in a disconnected graph can be split
up into different subgraphs, the so-called components, which are
not connected among one another. A component is a maximal con-
nected subgraph (Wasserman and Faust, 1994). To further examine
this property, we calculate the size of the largest component and
the number of isolated, i.e. disconnected, nodes.
The density of a graph describes the general level of linkages
among its nodes. The density is defined as the actual number of
connections (edges) of a graph divided by the maximal possible
number of edges:
 =
∑
d(ni)
g(g − 1) (1)
where g is the group size, i.e. the number of nodes in the graph,
and d(ni) is the degree of node i. The degree of a node represents
its actual ties to other nodes. The density can take values between
0 and 1. Since it is an average, one has to be careful with its inter-
pretation because the variation of the number of ties may  be very
high. The density of a graph is influenced by the number of isolated
nodes, since they have by definition a degree of zero.
The mean nodal degree d reports the average degree, i.e. the
average number of ties of a node ni, of all actors in the network.
d =
∑g
i=1d(ni)
g
(2)We  can transform the mean degree d into the density  by dividing
it with g − 1.
Actors can be defined as central if they are involved in many
relationships within the network. We calculate different centrality
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easures, indicating to what extend actors show high or low levels
f centrality and how heterogeneous actors’ centrality scores are
istributed. One of the simplest definitions of actor centrality states
hat central actors have to be actively engaged in the network and
hus possess a high number of linkages to other actors. Following
his idea, many researchers have used the degree of an node as a
entrality measure on the individual basis (see Freeman, 1979 for
n overview):
D(ni) = d(ni) (3)
ince this measure depends on the group size, g, it has to be
tandardized in order to use it for comparisons across different
etworks.
′
D(ni) =
d(ni)
g − 1 (4)
n accordance with the definition of prominence by Knoke and Burt
1983) an actor with a high centrality level is among the most visible
nes in the network, being directly connected or adjacent to many
thers. Actors with low degrees are peripheral to the network and
hus less active in the relational process and the information flows.
n an extreme case, an actor may  be completely isolated.
Following Freeman (1979), we can use the measure of actors’
egree centrality to construct a general index of graph centraliza-
ion:
D =
∑g
i=1[CD(n
∗) − CD(ni)]
max
∑g
i=1[CD(n
∗) − CD(ni)]
(5)
n the numerator, CD(ni) refers to the g actor degree indices and
D(n*) to the largest observed degree index. Degree centralization
f a graph can be expressed by the observed variation in the actor’s
egree indices (numerator) divided by the maximum possible vari-
tion (denominator). The denominator can be expressed directly by
g − 1)(g − 2) (cf. Freeman, 1979), leading to:
D =
∑g
i=1[CD(n
∗) − CD(ni)]
[(g − 1)(g − 2)] (6)
q. (6) gives an index of the degree of centralization of the network’s
et of actors. Moreover, it can be interpreted as a measure of disper-
ion of the actor’s degree indices, since the latter ones are compared
o the maximum value. The degree centralization index equals its
aximum value of one if a single, central, actor is related to all other
 − 1 actors, who themselves only interact with the central actor.
his is precisely the situation we can find in an ideal star graph. The
inimum value of zero is attained if all degrees are equal. This is
he case in a regular graph that would correspond to a circle graph
Wasserman and Faust, 1994).
Interactions between non-neighboring nodes are likely to
epend on other actors, particularly those lying on the path
etween the two. The latter ones may  play a control or interme-
iary role concerning the interactions between the other nodes,
hich can be highly valuable for the entire network. The between-
ess centrality of a node measures the extent to which this node
an be seen as a gatekeeper or broker in the network. This idea
as been used to construct the measure of betweenness centrality,
hich can be considered as the probability that a path within the
etwork takes a particular route. The underlying assumptions are
hat all edges have equal weight and that the shortest path is used.
reeman (1977) operationalized the idea as the actors’ between-
ess index, which is the sum of all the estimated probabilities over
ll pairs of actors not including the ith actor:
B(ni) =
∑
j<k
gjk(ni)
gjk
(7)olicy 43 (2014) 333– 348
With i being distinct from j and k, let gjk(ni) denote the total number
of shortest paths linking actors j and k containing actor i. The proba-
bility that two  actors, j and k, are linked by an distinct actor i is given
by gjk(ni)/gjk. The index CB(ni), which accounts for i’s betweenness
with respect to all actors j and k, can be standardized so that it
takes values between 0 and 1 and can be compared between among
different actors and networks:
C ′B(ni) =
2 × CB(ni)
(g − 1)(g − 2) (8)
The application of group betweenness centralization measures
allows us to compare different networks with respect to the varia-
tion of the actors’ betweenness. According to Freeman (1977, 1979),
we can express the group betweenness centralization index as:
CB =
2
∑g
i=1[CB(n
∗) − CB(ni)]
[(g − 1)2(g − 2)]
(9)
In the numerator, CB(ni) represents the actor betweenness index
and CB(n*) its largest realization. The denominator is the numera-
tor’s largest possible value. The index reaches its maximum value
of one in a star network, whereas the minimum value of zero is
reached if all actors have the same betweenness, i.e. in case of a
line graph.
Within a network, a path can be characterized as a walk through
the net where all edges and all nodes are distinct. The length of a
path is its number of edges. The average path length is defined as
the average number of edges along the shortest paths between all
nodes of the network:
L = 1
g × (g − 1) ×
∑
i /=  j
dij (10)
where dij denotes the shortest path between the nodes i and j. The
average path length is a structural property of network graphs to
determine whether a network fits the small world properties or not
(Watts and Strogatz, 1998).
Another indicator that can be used to test the networks’ small
world properties is the clustering coefficient or transitivity. The
intuition behind this measure is the question as to whether two
actors connected to a third one interact among one another, too.
Accordingly, the clustering coefficient measures the degree to
which the nodes of the network tend to cluster together, which
can be interpreted as the cohesion of the network. A triad involv-
ing the actors i, j and k is transitive if i is connected to j  as well as j
to k and i to k (Wasserman and Faust, 1994). For the entire graph,
we can compute the global clustering coefficient as the ratio of the
number of triads N and the number of connected triples N3 in the
graph.
CC = 3 × N
N3
(11)
The clustering coefficient can be interpreted as the probability that
two neighbors of an actor in the network are connected.
The point connectivity and the geodesic count can be used to
assess the connectivity of nodes within a network. More precisely,
the point connectivity of each node in the network is defined as the
minimum number of other nodes that have to be removed from the
network in order to disconnect a pair of nodes. The geodesic count
refers to the number of shortest paths connecting two nodes in the
network.
3.2. Network regressionsIn order to examine the endogenous mechanisms that drive
dynamics of the cross-country collaboration network in pharma-
ceuticals not only on an descriptive basis, we use multiple
arch P
r
K
t
Y
T
t
o
t
a
d
y
A
i
G
y
H
o
c
e
c
c
t
a
b
r
c
a
m
m
i
p
s
S
e
d
c
m
u
w
a
s
2
r
n
o
o
m
that have been assigned to at least one publication in the respec-
tive therapeutic area and period. Country level publication data
is matched with World Bank income groups in order to haveU. Cantner, B. Rake / Rese
egression techniques for dyadic data (Butts and Carley, 2001;
rackhardt, 1988). Following Krackhardt (1987), we can describe
he relations within a network by a n × n adjacency matrix Y:
 =
⎛
⎜⎜⎜⎜⎝
0 y1,2 . . . y1,n−1 y1,n
y2,1 0 . . . y2,n−1 y2,n
...
...
. . .
...
...
yn,1 yn,2 . . . yn,n−1 0
⎞
⎟⎟⎟⎟⎠
(12)
he elements yi,j of the matrix Y equal zero if there is no rela-
ion between actor i and actor j and are equal to any other value
therwise. Thus, the values of yi,j indicate the strength of the rela-
ion between both actors. For the use in regression techniques, the
djacency matrix Y is transformed into a vector form, without the
iagonal elements:
 =
⎛
⎜⎜⎜⎜⎝
y1,2
y1,3
...
yn,n−1
⎞
⎟⎟⎟⎟⎠
(13)
pplying this transformation to all variables leads to the general-
zed regression equation for undirected relations (cf. Cantner and
raf, 2006):
ij =  ˛ + ˇ′xij + ij for all i < j (14)
ere, the dependent variable yij may  refer to the amount of collab-
ration between i and j or, as in our analytical framework, to the
hange in the amount of collaboration. x is a matrix containing the
xplanatory variables related to the actor pair i and j. This model
an be estimated using standard OLS regression techniques. The
oefficients are interpreted in the usual way.
Social network data require different techniques to examine
he coefficients and particularly their the significance, since the
ssumptions of the standard OLS model are usually violated, e.g.
y structural autocorrelation, which frequently appears either in
ows or columns of the network matrix (Krackhardt, 1987). Thus,
onventional test statistics may  provide misleading standard errors
nd significance levels. The multiple regression quadratic assign-
ent procedure (MRQAP) has been found to be an appropriate
ethod to derive more correct inferences concerning the signif-
cance of the model’s coefficients (Hubert, 1987). This procedure
rovides a general, permutation-based, non-parametric test of the
ignificant relation of two structures (see among others Hubert and
chultz, 1976; Mantel, 1967). The general idea of MRQAP is to gen-
rate the reference distribution by random permutation of original
ata matrix’ rows and columns against which the coefficients are
ompared. All rows and columns of the matrix are identically per-
uted, which ensures that the structure of the matrix remains
nchanged, except for those referring to the order of the objects
ithin the matrix (Dekker et al., 2007; Nagpaul, 2003).
The MRQAP procedure has been found to be quite robust against
utocorrelation encountered in network data. We  use the double
emi-partialing method (DSP) proposed by Dekker et al. (2007,
003), since it provides a version of the MRQAP procedure that is
obust against multicollinearity and other conditions such as skew-
ess of the data. MRQAP models require a relatively large number
f random permutations. In our study, we use 10,000 replications
f this procedure, since this number allows for a sufficient approxi-
ation of the reference distribution (cf. Jackson and Somers, 1989).olicy 43 (2014) 333– 348 339
3.3. Data
Our empirical analysis is performed on a unique dataset of pub-
lications in scientific journals related to pharmaceutical research.
It was constructed by using different data sources in the follow-
ing way: First, a list of 251 medical indications was drawn from the
BioPharmInsight database.2 Each indication represents a condition,
disease or symptom, which allows for the development of a partic-
ular procedure or treatment. Each indication is exclusively assigned
to one out of 15 therapeutic areas that correspond to a system
of an organism or a general disease group.3 Therefore, indications
assigned to one and the same therapeutic area are considered to be
more related than indications that belong to different therapeutic
areas.
The list of medical indications was  used to conduct a keyword
search in the Web  of Science databases (WoS). The WoS  con-
sist of seven databases containing information gathered from an
extensive number of journals, books, book series, reports and con-
ferences. Among these databases, the most important is the Science
Citation Index Expanded (SCI), a multidisciplinary index of more
than 6500 scientific journals, covering 150 scientific disciplines.
The SCI covers, among others, the scientific fields of biochemistry,
medicine and pharmacology which are of particular interest for
our study. The WoS  includes information concerning the scientific
publications themselves, such as the title, the year of publication,
the journal, cited references, a categorization of the research fields,
to which a publication can be assigned, and further bibliographic
information. In addition to this information, the WoS  reports for
most articles the authors’ affiliations and their addresses including
the country of origin. However, prior to 2008, it is not possible to
match authors with their affiliations.
Publications that contain at least one medical indication from
our keyword list in their title have been included in our dataset. In
order to refine the results, we only take into account publications
included in categories related to pharmaceutical research. More
precisely, articles assigned to the subcategories “Biochemistry &
Molecular Biology”, “Biotechnology and Applied Microbiology”,
“Chemistry, Applied”, “Chemistry, Medicinal”, “Medicine, Research
& Experimental”, “Pharmacology & Pharmacy” and “Toxicology” are
included.4 We  restrict our sample to journal articles and exclude
journal publications that are labeled as meeting abstracts, editorials
or reviews, as well as other non-journal publications. Conference
proceedings have not been considered either, since they might
be of different quality compared to published papers and may  be
already included as published articles in the dataset. For the period
from 1998 to 2008, we  obtain 113,057 articles. We further restrict
our sample to all articles that contain information concerning the
authors’ affiliations. In total, our sample consists of the 111,096
journal articles. In order to analyze the development of cross-
country scientific collaboration over time, we distinguish three sub
periods, 1998–2000, 2002–2004, and 2006–2008. We  do not take
the years 2001 and 2005 into account in order to have periods of
equal length and to have a clear separation among the sub periods.
We use the reported author affiliations to extract informa-
tion concerning the countries of origin of the scientific articles in
our dataset. Consequently, our networks encompass all countries2 http://www.infinata5.com/biopharm/.
3 Table 6 (see Appendix A.1.) provides an overview of the therapeutic areas
included in the dataset.
4 The subcategories are described in detail at http://scientific.thomsonreuters.
com/mjl/.
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ome information concerning the wealth level of the countries
n our sample. Articles in the categories “Biochemistry & Molec-
lar Biology” and “Biotechnology and Applied Microbiology” are
egarded as biotechnology publications. The CHI classification of
ournals (Hamilton, 2003) gives us the opportunity to classify each
rticle according to the type of research prevalent in the jour-
al, in which it is published. The application of this classification
cheme enables us to distinguish “clinical observation”, “clinical
ix”, “clinical investigation”, and “basic biomedical research” pub-
ications. We  employ the CEPII (Centre d’Études Prospectives et
’Information Internationales) database on distance measures in
rder to get information concerning language similarities among
ountries (Mayer and Zignago, 2006). We  use the World Bank Sci-
nce & Technology database in order to get information concerning
he overall scientific output of country in terms of journal articles
n scientific and technical journals.
Publication data provide the advantage of getting access to
ighly detailed information included in scientific articles that are
sually available for a long time span. However, there are some
rawbacks that have to be taken into account when analyzing
o-publication data. The most important are that research does
ot necessarily lead to publication, co-authorship may  only partly
apture scientific collaboration, the impact of publications dif-
ers considerably and publication habits differ among scientific
isciplines. Publication databases may  be biased towards English
anguage publications and journals published in industrialized
ountries. Although researchers using co-publication data face the
entioned shortcomings, this type of data has been found to be an
ppropriate indicator for scientific collaboration if large datasets,
oncentrated in one scientific field and aggregated on the coun-
ry level, are used (see e.g. Katz and Martin, 1997; Laudel, 2002;
undberg et al., 2006; Hoekman et al., 2009 for a discussion).
. International research networks
.1. Network descriptives
In this section, we employ social network analysis to analyze
ifferences in the cross-country collaboration patterns in pharma-
eutical research in various therapeutic areas. We  use the igraph
ackage by Garbor Csardi and netmodels package by Domingo
argas for R statistical software to calculate descriptive network
tatistics.
We start our analysis taking into account all journal publications
n the respective therapeutic areas and periods. The descriptive
etwork statistics presented in Table 1 reveal some general trends
n the development of cross-country networks of pharmaceutical
esearch. The number of countries participating in the cross-
ountry research community and the relative size of the largest
omponent, i.e. the largest group of connected countries, increase
n almost all therapeutic areas, from the first to the third period. This
orresponds to a decrease in the share of isolated countries, which
o not collaborate with other countries. However, their absolute
umber increases in eight therapeutic areas.
Most networks show an increase in their density from the first
o the third period, which indicates that the number of realized
inkages grows faster than the number of countries. However, the
ensity remains quite close to its minimum value of 0 in all subnet-
orks. In most networks, the increasing trend is not stable, i.e. that
he density decreases in at least one period. The highest share of
ealized compared to possible linkages, 14.1%, is reached in the area
f central nervous system research in the first period. The lowest
alue with 2.4% is observed in dermatology in the same period. With
 few exceptions, the mean number of other countries to which a
ountry is connected is increasing from the first to the third period.olicy 43 (2014) 333– 348
We  interpret this as a hint that the cross-country collaboration
intensity in pharmaceutical research increases over time.
The degree centralization measure equals values above 0.4 in
most networks over all three periods, indicating that the number
of linkages is quite dispersed among countries in the majority of
the analyzed networks. This finding indicates that some countries
collaborate more than others. All betweenness centralization meas-
ures are below 0.42, which indicates some dispersion of these
measures among the countries in all subnetworks. Table 1 shows
that the average path length between countries is rather stable,
above 2 in most therapeutic areas. In 10 therapeutic areas, the
clustering coefficient as a measure for coherence of the network
increases, from the first to the third period, which can be seen as
another indicator of increasing cross-country collaboration.
We analyze which countries are located at central network
positions in Table 7 (see Appendix A.2.). In all therapeutic areas
high income OECD countries account for a substantial but declining
share of the countries in the networks. This development can be
explained by the entry of non-OECD countries. The connectivity
of OECD and non-OECD countries in terms of the mean degree of
countries increases over time. However, the mean degree of OECD
countries is considerably larger compared to the mean degree of
non-OECD countries in most therapeutic areas. We compute the
average betweenness centrality scores for OECD and non-OECD
countries to obtain some further information concerning the
position of these country groups in the network. The results reveal
that the average betweenness centrality scores increase over time
for both groups of countries while the scores of OECD countries
remain considerably larger than those of non-OECD countries.
Hence, we find that particularly OECD countries are located at
central positions within the network of cross-country scientific
collaborations. The results stay qualitatively similar if we drop
the United States as the country with the most publications and
collaborations from the analysis.
In further steps, we  restricted our analysis to basic research
and biotechnology publications in order to examine whether the
trend towards increasing collaboration described earlier can be
found in this subfield as well. The number of countries involved in
these types of research is, in general, somewhat lower compared
to the complete networks. Nevertheless, the number of involved
countries increases over time in most networks and the countries
increase collaboration among one another. As in the case of the
complete networks, high income OECD countries can be found in
the center whereas developing and newly industrializing countries
can be found in peripheral positions of the network. Consequently,
the cross-country research network in the fields of basic and
biotechnology research show similar patterns as the networks,
including all journal articles in the respective therapeutic areas.
In order to ensure that the increasing cross-country collaboration
is not driven by an expanding number of journals, we  restrict our
sample to those journals that have been included in the WoS  prior to
1998 according to the CHI classification. The results for this subsam-
ple are in line with the original analysis. The analysis of weighted
instead of binary networks reveals a trend towards increasing
collaboration and cohesion. The mean degree, the average collab-
oration intensity, and the clustering coefficient are increasing over
time in all therapeutic areas. Again, high income OECD countries
can be found in central positions within the networks.
4.2. Entry and exit
In the previous section, network statistics seem to indicate
intensified collaboration across countries in almost all therapeutic
areas. We find that an increasing number of countries are engaged
in collaborative pharmaceutical research across borders. In this
section, we analyze the number of entries, exits and persistently
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Table 1
Network descriptive statistics.
Therapeutic
area ID
Period Number of
countries
Number of
components
Abs. size largest
component
Rel. size largest
component
Abs. number
of  isolates
Rel. number of
isolates
Density Mean degree Degree
centralization
Betweenness
centralization
Average path
length
Clustering
coefficient
All 1 136 7 130 0.956 6 0.044 0.107 14.397 0.576 0.221 2.070 0.427
All  2 141 9 133 0.943 8 0.057 0.119 16.723 0.582 0.195 2.045 0.487
All  3 154 1 154 1.000 0 0.000 0.136 20.779 0.597 0.167 2.068 0.499
1  1 73 11 63 0.863 10 0.137 0.109 7.863 0.530 0.244 2.091 0.449
1  2 84 9 76 0.905 8 0.095 0.120 9.929 0.556 0.221 2.098 0.483
1  3 101 7 95 0.941 6 0.059 0.127 12.673 0.554 0.212 2.092 0.492
2  1 73 15 58 0.795 13 0.178 0.091 6.548 0.449 0.166 2.184 0.443
2  2 84 15 70 0.833 14 0.167 0.082 6.786 0.422 0.157 2.309 0.443
2  3 89 15 75 0.843 14 0.157 0.118 10.382 0.402 0.122 2.226 0.535
3  1 56 7 50 0.893 6 0.107 0.141 7.750 0.495 0.259 2.024 0.512
3  2 68 9 60 0.882 8 0.118 0.123 8.235 0.596 0.286 2.023 0.453
3  3 79 10 70 0.886 9 0.114 0.127 9.899 0.527 0.207 2.082 0.500
4  1 31 20 5 0.161 16 0.516 0.024 0.710 0.117 0.013 1.565 0.000
4  2 32 17 16 0.500 16 0.500 0.054 1.688 0.183 0.113 2.358 0.510
4  3 35 18 18 0.514 17 0.486 0.049 1.657 0.260 0.153 2.418 0.351
6  1 48 16 33 0.688 15 0.313 0.058 2.708 0.406 0.242 2.388 0.297
6  2 54 12 43 0.796 11 0.204 0.084 4.444 0.481 0.307 2.174 0.353
6  3 69 16 53 0.768 14 0.203 0.067 4.580 0.491 0.254 2.146 0.337
7  1 67 16 51 0.761 14 0.209 0.071 4.687 0.364 0.200 2.460 0.451
7  2 68 14 55 0.809 13 0.191 0.083 5.559 0.499 0.242 2.221 0.432
7  3 77 14 64 0.831 13 0.169 0.096 7.325 0.482 0.175 2.185 0.430
8  1 42 14 29 0.690 13 0.310 0.057 2.333 0.401 0.326 2.495 0.282
8  2 44 14 30 0.682 12 0.273 0.056 2.409 0.429 0.319 2.326 0.274
8  3 55 12 44 0.800 11 0.200 0.071 3.855 0.464 0.337 2.314 0.347
9  1 59 14 44 0.746 12 0.203 0.061 3.525 0.276 0.190 2.526 0.383
9  2 55 14 41 0.745 12 0.218 0.065 3.491 0.433 0.265 2.352 0.305
9  3 63 14 50 0.794 13 0.206 0.084 5.206 0.513 0.345 2.287 0.528
10  1 24 11 14 0.583 10 0.417 0.098 2.250 0.415 0.168 1.824 0.425
10  2 28 11 18 0.643 10 0.357 0.074 2.000 0.439 0.271 2.078 0.250
10  3 38 14 25 0.658 13 0.342 0.077 2.842 0.318 0.165 2.307 0.414
11  1 59 15 44 0.746 13 0.220 0.063 3.627 0.399 0.261 2.317 0.314
11  2 64 12 53 0.828 11 0.172 0.082 5.156 0.473 0.315 2.294 0.384
11  3 72 12 61 0.847 11 0.153 0.129 9.194 0.446 0.154 2.086 0.515
12  1 58 8 50 0.862 6 0.103 0.084 4.793 0.603 0.419 2.151 0.282
12  2 56 11 45 0.804 9 0.161 0.110 6.071 0.489 0.262 2.053 0.475
12  3 72 12 61 0.847 11 0.153 0.103 7.306 0.474 0.197 2.168 0.484
13  1 116 13 104 0.897 12 0.103 0.080 9.224 0.458 0.186 2.189 0.359
13  2 121 7 115 0.950 6 0.050 0.109 13.091 0.508 0.206 2.154 0.467
13  3 132 4 129 0.977 3 0.023 0.111 14.576 0.585 0.188 2.104 0.399
15  1 50 15 34 0.680 12 0.240 0.080 3.920 0.384 0.152 2.062 0.352
15  2 52 11 42 0.808 10 0.192 0.102 5.192 0.465 0.194 2.156 0.399
15  3 65 16 50 0.769 15 0.231 0.072 4.585 0.474 0.253 2.274 0.385
16  1 45 12 27 0.600 8 0.178 0.084 3.689 0.293 0.109 2.000 0.433
16  2 44 13 31 0.705 11 0.250 0.122 5.227 0.360 0.159 2.026 0.505
16  3 54 15 39 0.722 13 0.241 0.091 4.815 0.376 0.181 2.082 0.423
17  1 67 7 61 0.910 6 0.090 0.112 7.373 0.447 0.308 2.268 0.465
17  2 62 11 52 0.839 10 0.161 0.106 6.484 0.483 0.203 2.127 0.436
17  3 77 10 68 0.883 9 0.117 0.095 7.195 0.484 0.211 2.277 0.403
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ontributing countries. In doing so, we calculate the mean degree,
.e. the average number of connections a country has, for the three
ubgroups mentioned. The connectivity of countries within the net-
ork may  be associated with their research performance and their
ecision to leave the network. Based on evidence on the individual
nd organizational level, we expect countries to leave the network
ecause of a weak position therein, i.e. a relatively low number of
onnections to other countries (cf. Cantner and Graf, 2006; Powell
t al., 1999).
Table 2 reveals a considerable number of entries and exits from
he first to the second and from the second to the third period in
ll therapeutic areas. In 13 out of 15 therapeutic areas, at least
en countries enter, and in six therapeutic areas, the number of
xits is at least ten in the period 2002 to 2004. The number of
ntering countries exceeds the number of exits in eleven thera-
eutic areas. In the third period, we find positive net entry and
ore than ten entering countries in all therapeutic areas. However,
he number of exits increased in six therapeutic areas compared
o the previous period. The positive net entry in most therapeutic
reas, particularly in the third period, suggests, again, that scientific
ollaboration in pharmaceuticals has become more international.
oreover, entries and exits give us some hint that there is some
ynamic in the formation and break-up of ties within the networks.
With respect to the mean degree of each subgroup, entering,
xiting and permanent countries (incumbents), we  find consid-
rable differences in all therapeutic areas among these groups.
ncumbents are connected to a by far higher number of other
ountries than entering and exiting countries.5 This finding is
revalent for entries and exits from the first to the second and
rom the second to the third period. With respect to the exiting
ountries, we interpret this as a hint that these countries left the
ross-country research network because of a relatively weak posi-
ion in the respective field in terms of international contacts. For
ountries entering in the third period, we find, on average, a higher
umber of connections than for exiting countries. Nevertheless,
ntering countries are far less connected than incumbents. The lat-
er increase their average number of collaborative ties in 13 out
f 15 therapeutic areas. This finding indicates that these countries
ncreasingly engage in cross-country research collaboration.
The networks taking into account only basic research, biotech-
ology and articles published in journals included in the WoS  prior
o 1998 show very similar patterns of entry and exit. Again, the
umber of entries and exits is considerable and exiting countries
re far less connected than incumbents.
. Empirical results network regressions
.1. Variables
We  present here an overview of the variables and controls used
n our network regression models in Table 3. Descriptive statistics
re presented in Table 4. The dependent variable is the change in
he number of total collaboration between two countries between
eriod t − 1 and period t. More precisely, we calculate the amount
f collaboration for each pair of countries in period t and subtract
he amount of collaboration in period t − 1. This variable captures
hanges in the intensity of collaboration activities, the formation
f collaboration ties between previously unconnected countries as
ell as the break-up of any previously existing ties. Collaboration
ctivities are measured via co-publication activities. The number
f co-publications between each pair of countries is calculated
ased on author affiliations. We  use full counting, which leads to a
5 The mean degree for exiting countries refers to the previous period in which
hey were part of the network. T
ab
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Table  3
Overview of variables.
Dependent variable
Collaboration Change in the number of collaborations between two countries
from period t − 1 to t
Independent variables
Diff DegreeCentrality Connectedness Difference in the degree centrality between two countries
lagged by one period
Collaboration Connectedness Amount of collaboration between two countries lagged by one
period
IncomeSimilarity Similarity Dummy indicating whether two  countries belong to the same
income group
LanguageSimilarity Similarity Dummy indicating if at least 9% of the population in both
countries speak the same language
Diff  ResearchStrength Similarity Difference in the total number of science and technology
articles per one million inhabitants between two  countries
lagged by one period
PointConnectivity Multi-connectivity Number of other countries that have to be removed in order to
disconnect two countries lagged by one period
GeodesicCount Multi-connectivity Number of shortest paths between two countries lagged by
one period
Table 4
Descriptive statistics explanatory variables MRQAP regression.
Variable Period Observations Mean Std. Dev. Min  Max
Collaboration 2 13110 0.688 11.788 −217.000 721.000
3  15500 1.427 22.573 −141.000 1347.000
Diff  DegreeCentrality 2 13110 0.065 0.114 0.000 0.674
3  15500 0.070 0.116 0.000 0.693
Collaboration 2 13110 1.430 21.751 0.000 1368.000
3  15500 1.798 26.759 0.000 1371.000
IncomeSimilarity 2 13110 0.097 0.296 0.000 1.000
3  15500 0.093 0.291 0.000 1.000
LanguageSimilarity 2 13110 0.061 0.240 0.000 1.000
3  15500 0.058 0.234 0.000 1.000
Diff ResearchStrength 2 13110 115.374 241.692 0.000 1151.029
3  15500 113.039 238.097 0.000 1121.178
PointConnectivity 2 13110 3.601 6.678 0.000 67.000
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In Table 5, we present the results of our regression analy-
sis on the formation and break-up of network ties as measured3  15500 
GeodesicCount 2 13110 
3  15500 
o-publication count of one for each pair of countries involved in a
ublication. Since co-publications represent undirected links, each
air of countries is included only once in a specific period and
herapeutic area.
With respect to the independent variables, we draw upon
ultiple measures in order to test the different mechanisms of
ndogenous network dynamics presented in Section 2.2. With
espect to connectedness we distinguish differences in the degree
f connectedness in the network between two  countries and the
egree by which two countries are connected. For the former
hich draws on the network embeddedness of a country we  follow
lückler (2010) and use absolute differences in countries’ degree
entrality scores lagged by one period as a proxy for connected-
ess (Diff DegreeCentrality). This measure refers to differences in
he visibility of countries in the research network. For the latter
hich addresses the direct connectedness of two  countries, the
umber of prior ties has been used as an indicator for an accumula-
ive advantage based on previous connectedness (cf. Powell et al.,
005). Therefore, we include in our analysis the number of previous
ollaboration among two countries lagged by one period (Collabo-
ation).
With respect to similarities between countries we distin-
uish three dimensions. A first one is reflected by the variable
ncomeSimilarity indicating whether two collaborating countries
elong to the same World Bank income group, i.e. they have compa-
able wealth levels. We  use language similarities among countries
s a second measure for similarity. More precisely, LanguageSimilar-
ty equals 1 if at least 9% of the population speaks the same language.4 7.878 0.000 75.000
3 4.141 0.000 94.000
9 4.726 0.000 90.000
Third, Diff ResearchStrength accounts for similarities in the research
strength of two  countries. To obtain this measure, we  calculate the
difference in the total number of articles in science and technol-
ogy journals per one million inhabitants lagged by one period.6
Multi-connectivity is captured by the point connectivity for each
country pair lagged by one period (PointConnectivity). This measure
indicates the number of other countries that have to be removed
from the network in order to disconnect two  (prospectively) col-
laborating countries. Moreover, we use the number of shortest
paths between two countries in the network with a lag of one
period (GeodesicCount) as a further proxy for multi-connectivity
(cf. Glückler, 2010). These two measures, although addressing the
same principle dimension, focus on different aspects of multi-
connectivity; PointConnectivity looks at the number of different
in-between countries whereas GeodesicCount counts the number
of shortest paths. For the latter, it has to be recalled that values
greater 1 imply no direct connections between two countries.
5.2. Regression results6 According to the World Bank Science & Technology database this measure
includes articles from a broad variety of fields including physics, biology, chemistry,
mathematics, clinical medicine, biomedical research, engineering and technology,
and earth and space sciences.
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Table  5
Network regression.
Period 2 Period 3
(1) (2) (3) (4)
Estimate Pr(≥|b|) Estimate Pr(≥|b|) Estimate Pr(≥|b|) Estimate Pr(≥|b|)
Dependent variable: Collaboration
Diff DegreeCentrality 5.3585 0.0127 9.9599 0.0003 2.3331 0.1273 5.6178 0.0242
Collaboration 0.2066 0.0000 0.1986 0.0000 0.6050 0.0000 0.6017 0.0000
IncomeSimilarity 0.9575 0.1141 0.4890 0.3677 −0.6612 0.2279 −1.1592 0.0907
LanguageSimilarity −1.2698 0.0955 −1.4303 0.0772 1.1834 0.0923 1.2593 0.0886
Diff  ResearchStrength −0.0045 0.0010 −0.0026 0.0425
PointConnectivity 0.3179 0.0000 0.3741 0.0000 0.1841 0.0000 0.2277 0.0001
GeodesicCount −0.2228 0.0032 −0.2035 0.0049 −0.0665 0.0678 −0.0710 0.0698
Intercept −0.5978 0.1333 −0.5206 0.1656 −0.3934 0.2237 −0.3755 0.2413
Residual standard error 13.17 13.04 15.37 15.69
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oF-statistic (p-value) 323.5 0.0000 274.7 
Adjusted R-squared 0.2279 0.2345 
ullhypothesis: MRQAP with DSP and 10,000 permutations.
y the change in the number of total collaboration between two
ountries. We  perform our analysis on the aggregated or pooled
evel, i.e. we do not distinguish among the different therapeu-
ic areas and we concentrate on countries that are members of
he network in periods t − 1 and t, the incumbent countries. For
hat sample we can use most of our independent variables as
agged by one period allowing us an analysis that goes beyond pure
orrelation and delivers some insight into the factors and mech-
nisms driving the formation and the break-up of ties within a
etwork.7 Network correlations of the independent variables can
e found in Tables 8 and 9 (see Appendix A.3.). Since the cor-
elation between Diff ResearchStrength and Diff DegreeCentrality is
uite high, we present separate models that include and do not
nclude Diff ResearchStrength. Nevertheless, the MRQAP procedure
ith double semi-partialing permutation is supposed to be quite
obust against multi-collinearity (Dekker et al., 2007, 2003). Results
ot presented in the paper are available upon request.
With respect to Hypothesis 1a and relative connectedness as a
river of tie formation, we find a positive and significant coeffi-
ient for Diff DegreeCentrality in period 2 and when we  introduce
he variable together with Diff ResearchStrength in period 3. For
he second period, this indicates a positive relation between dif-
erences in the degree centrality of countries lagged by one period
nd changes in the intensity of collaboration. Hence, a larger differ-
nce of countries in terms of their relative connectedness promotes
urther collaboration ties among them implying that new or inten-
ified collaboration will take place between unequally embedded
ountries whereas the break-up of ties will be observed more
ikely between more equally embedded countries. Since the respec-
ive coefficient is not significant in model (3) for the third period,
esults are not robust with respect to time. The indicator for bilat-
ral connectedness proxied by Collaboration, shows a positive and
ignificant association towards changes in the amount of collabo-
ation between two countries in subsequent periods.8 This result
7 Ideally, tie formation of entering countries would give some insights concerning
he mechanisms driving the dynamics of the network. However, the problem with
his  approach is that lagged variables for entrants are not available, which makes it
ard to identify the mechanisms at work with more sophisticated methods. There-
ore, we concentrate on tie formation and break up among incumbents for which
agged variables are available.
8 Collaboration is the main source of differences in the adjusted R-squared, since
t  contributes much less to this measure in period 2 compared to period 3. We
ccount for the possibility that the Collaboration variable dominates our results.
ore precisely, we  run additional regressions without the Collaboration variable
sing the number of collaborations among countries that did not collaborate in the
revious period as dependent variable. The results are qualitatively similar to those
btained in the original analysis..0000 1672 0.0000 1377 0.0000
0.5641 0.5657
can be interpreted as a hint that countries’ bilateral connectedness
measured by previous collaboration can lead to an accumulative
advantage based on connectedness which induces further collab-
oration activities as suggested by Hypothesis 1b. Put differently,
a joint collaboration experience may  lead to a self-reinforcing
process of intensified collaboration in which countries that have
been well connected in previous periods form more intensely new
ties among each other. Taken our two  results for connectedness
together, we find evidence for the existence of a “rich-get-richer”
phenomenon in which the well-connected countries can further
increase their connectivity. These findings are to a wide extent in
line with the theoretical predictions underlying Hypotheses 1a and
1b.
Similarity dimensions are at the core of Hypothesis 2. Similarity
in terms of countries being in the same income group (IncomeSim-
ilarity) is, with an exception in model (4), not significantly related
to the formation and break-up of research collaboration. Hence,
our results do not suggest that either similarities or differences in
terms of income groups are robustly associated with changes in the
amount of collaboration. With respect to language similarities (Lan-
guageSimilarity), we find a weakly significant negative relationship
of the same language spoken in two countries and tie formation and
break-up in period 2. However, in period 3, we find a weakly signif-
icant positive association. Consequently, our results do not suggest
that similarity in terms of language among countries has a robust,
clear-cut relationship to changes in the amount of collaboration at
the country-level. Differences in the total number of science and
technology journal articles per one million inhabitants as an indi-
cator for differences in the strength of countries’ science systems
(Diff ResearchStrength) are negatively and significantly related to
the formation and break-up of research collaboration. This find-
ing suggests that a higher similarity of countries in terms of their
population adjusted scientific output leads to increasing interac-
tions among these countries. Taken these three results together, we
find that some particular forms of similarity among countries affect
the dynamics of international collaboration activities in pharma-
ceutical research while others do not. Neither countries’ economic
nor language similarities (taking also into account that the lin-
gua franca in science is English) are linked to the dynamics of
international collaboration activities in pharmaceutical research.
In contrast to these findings, the general research performance of
the respective national research and innovation systems proxied
by the total number of science and technology articles is positively
linked to changes in the intensity of scientific collaborations across
countries as suggested by theoretical concept of similarity based
network dynamics. The latter finding supports Hypothesis 2 and
indicates that a similar level of research intensity promotes mutual
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nderstanding and provide the basis for cross-country research
ollaboration.
Via Hypothesis 3 we analyze whether multi-connectivity,
ccounting for countries’ bilateral network attractiveness, is suit-
ble to explain changes in the amount of research collaboration
n the country level and find a positive and significant coeffi-
ient for PointConnectivity.  This finding suggests that changes in
he intensity of collaboration are positively related to the number
f countries that indirectly connect two other countries. Put differ-
ntly, the intensity of collaboration may  change due to knowledge
ows the partners receive through other collaboration. The coef-
cient for GeodesicCount,  i.e. the number of shortest paths, has a
ignificantly negative sign in both periods. The sign of the coef-
cient is rather intuitive, since a high number of shortest paths
ndicates that there has been no direct interaction among two
ountries, which is also shown by the slightly negative correlation
etween Collaboration and GeodesicCount in Tables 8 and 9 (see
ppendix A.3.). Hence, our results suggest that multiple shortest
aths as a proxy for multi-connectivity are negatively associated
ith tie formation and break up in both periods. Taken these two
esults together we find good support for Hypothesis 3. As the the-
retical concept of multi-connectivity would predict, there appears
o be a positive relation between indirect ties of two  countries
nd changes in their cross-country research collaborations which is
nly reduced when the two countries have been not or only weakly
onnected directly.
Our results for all three hypothesis stay qualitatively similar if
e restrict our sample to collaboration in the fields of basic and
iotechnology research, as well as to those journals included in the
oS  prior to 1998. Moreover, we obtain similar results when we
dditionally control for isolated countries that did not collaborate
n the previous period.
. Conclusion
Literature suggests that knowledge production and scien-
ific research are increasingly conducted in collaborative work
etween different authors and institutions. Moreover, collabora-
ion becomes increasingly more international, particularly in the
harmaceutical industry. In this study, we analyzed pharmaceuti-
al research collaboration networks at the country level in different
herapeutic areas. Our empirical analysis is based on a unique
ataset of journal publications related to pharmaceutical research.
y means of social network analysis, we find that the cross-country
esearch networks expand over time in almost all therapeutic
reas. More specifically, the number of countries involved and their
onnectivity increases in most therapeutic areas. High income
ECD countries are located in the core of the cross-country research
etworks. This pattern remains rather stable over time.
In order to assess which mechanisms, namely connectedness,
imilarity, or multi-connectivity, drive the endogenous network
ynamics, we employ multiple regression analysis for dyadic data.
ore precisely, we use the MRQAP procedure with double semi-
artialing permutation. Our regression results reveal a positive
ssociation between the connectedness of two countries as mea-
ured by the amount of previous research collaboration between
wo countries and the change in their amount of collaboration, indi-
ating an accumulative advantage based on the connectedness of
ountries. Differences in countries’ degree centrality as proxy for
onnectedness in terms of network embeddedness show no robust
ignificant relation to changes in the collaboration intensity. Our
esults do not allow for a clear-cut conclusion whether similari-
ies in terms of per capita income and language are driving in the
hange in cross-country collaboration. Differences in the strength
f countries’ research systems are, however, negatively related to
hanges in the collaboration intensity. Multi-connectivity in termsolicy 43 (2014) 333– 348 345
of different countries connecting two  other countries is positively
related, whereas the number of shortest paths shows a negative
association with changes in the amount of collaboration.
Our empirical results are in accordance with literature suggest-
ing the growing amount of collaborative work on the national and
international level (e.g. Mattsson et al., 2008; Adams et al., 2005).
Our measures of the network structures and the number of entries
and exits reveal that the cross-country networks are changing over
time. As to the driving mechanisms behind tie formation and break-
up we refer to the literature addressing a couple of different sources.
There has been empirical evidence for connectedness (e.g. Orsenigo
et al., 1998), similarity (e.g. Glückler, 2010), and multi-connectivity
(e.g. Powell et al., 2005) being the mechanism of tie formation in
different real world networks. Our regression results indicate that
these different mechanisms influence the formation and break-up
of ties between “collaborating countries”. Hence, the internation-
alization of research collaboration is influenced by the relative and
bilateral connectedness of countries indicating the presence of a
“rich-get-richer” phenomenon in which, as in the Barabási and
Albert (1999) model, already well connected countries increase
their connectivity even further. Additionally, we find that similari-
ties in terms of countries’ research strength supports the theoretical
argument and the empirical evidence of connections being prefer-
ably established between similar actors (McPherson et al., 2001).
These mechanisms may  lead to an increasing connectivity within
the network that implies the potential for knowledge transfer. In
order to secure this potential for (joint) knowledge generation and
recombination, countries engage in the formation of multiple paths
through to their collaboration partners as suggested by the multi-
connectivity approach (Powell et al., 2005).
Our results concerning the structure and the dynamics of the
international research networks in pharmaceuticals may  have
important policy implications. Countries that are not part of the
center of the network may  have difficulties to get access to the
sources of knowledge required for successful generation and usage
of pharmaceutical innovations. Therefore, policy makers may  sup-
port the access to the relevant knowledge sources by supporting
international collaboration between institutions from countries
located in the center of the pharmaceutical research networks
and countries located in the periphery. Countries located in the
networks’ periphery have typically few connections and are not
linked through multiple other countries to their collaboration part-
ners. Hence, the dynamics of the networks may weaken their
position even further by generating more new collaborations
between countries that belong to the core of the networks. Active
policy support is to be seen as an “entry ticket” into international
collaboration, a “ticket” that may  help to overcome the liabili-
ties of unconnectedness of countries that are not part of the core
of the network. When this first step is done, further advances
and steps of embedding into international collaboration networks
may follow rather automatically. Then, the experience gathered by
past collaborations and by building multiple connections to other
collaborating countries will be an important driver of further inte-
gration into the cross-country networks. Policy makers in countries
that are not part of the core of the network may  enforce such kind
of development by supporting and establishing direct linkages to
countries in the core or indirectly by investing more into their
national research and innovation system.
Since our investigation is restricted to pharmaceuticals, future
research may  focus on the development of cross-country research
collaboration in different industries. The pharmaceutical indus-
try may  provide an exceptional case due its pronounced scientific
foundation and the importance of (international) collaboration
networks. Hence, country level factors may  have different effects
for the structure and the dynamics of international research
networks in other fields.
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Table 6
List of therapeutic areas.
Therapeutic area Therapeutic area ID
Cancer 1
Cardiovascular 2
Central nervous system 3
Dermatology 4
Eye and ear 6
Gastrointestinal 7
Genitourinary 8
Hematological 9
HIV infections 10
Hormonal systems 11
Immune system 12
Infectious diseases 13
Musculoskeletal 15
T
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ppendix A.
.1. List of therapeutic areas.2. Network position of OECD countries
.3. Network correlations
Pain 16
able 7
etwork descriptive statistics OECD countries.
Therapeutic
area ID
Period Share OECD
countries in
network
Mean degree OECD
countries
M
co
All 1 0.199 26.111 1
All  2 0.191 30.889 1
All  3 0.175 38.519 2
1  1 0.370 13.852 
1  2 0.321 15.148 1
1  3 0.267 16.370 1
2  1 0.342 12.720 
2  2 0.298 14.480 
2  3 0.281 16.320 1
3  1 0.446 10.360 1
3  2 0.397 12.704 1
3  3 0.342 13.222 1
4  1 0.645 2.000 
4  2 0.688 3.409 
4  3 0.571 3.800 
6  1 0.479 5.217 
6  2 0.463 9.120 
6  3 0.348 9.083 
7  1 0.388 9.115 
7  2 0.368 9.720 
7  3 0.325 13.080 1
8  1 0.476 4.750 
8  2 0.477 4.571 
8  3 0.400 8.182 
9  1 0.407 6.333 
9  2 0.418 7.000 
9  3 0.413 8.769 
10  1 0.625 3.933 
10  2 0.464 3.462 
10  3 0.421 6.563 
11  1 0.424 7.680 
11  2 0.391 10.040 
11  3 0.347 14.640 
12  1 0.466 7.963 
12  2 0.446 9.840 
12  3 0.347 13.040 
13  1 0.233 18.074 1
13  2 0.223 20.037 1
13  3 0.205 24.593 1
15  1 0.500 7.480 
15  2 0.500 9.885 
15  3 0.369 7.833 Respiratory 17
ean degree non-OECD
untries
Mean betweenness
centrality OECD
countries
Mean betweenness
centrality non-OECD
countries
7.679 48.259 21.945
9.079 57.630 19.553
2.024 63.704 32.323
8.457 17.963 6.326
0.474 24.889 7.842
2.757 40.704 14.581
8.083 13.760 3.521
8.017 23.680 4.610
2.328 30.840 11.875
0.581 16.080 2.903
0.561 13.519 4.854
3.038 19.444 7.346
1.182 1.350 1.000
1.100 2.364 1.000
1.467 3.750 1.000
2.160 5.217 1.000
5.862 11.240 1.690
5.978 10.625 2.000
5.683 9.154 2.756
6.419 11.520 1.860
0.654 20.560 4.404
2.182 4.300 1.227
1.913 3.857 1.435
4.000 8.227 2.242
4.543 6.833 2.171
4.281 8.043 2.156
4.405 10.115 3.000
2.222 2.733 1.222
2.333 2.462 1.133
2.636 5.563 1.318
3.294 10.120 1.735
5.872 10.400 3.051
8.447 23.480 8.511
5.161 11.259 2.548
7.097 11.480 2.226
8.000 17.800 4.723
1.135 41.000 10.112
5.723 42.778 16.191
8.371 50.037 24.019
4.440 7.160 1.720
5.346 10.077 1.654
4.780 10.042 2.220
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Table  7 (Continued)
Therapeutic
area ID
Period Share OECD
countries in
network
Mean degree OECD
countries
Mean degree non-OECD
countries
Mean betweenness
centrality OECD
countries
Mean betweenness
centrality non-OECD
countries
16 1 0.511 6.304 4.136 6.522 1.409
16  2 0.545 9.208 5.150 7.417 1.850
16  3 0.444 8.208 3.767 11.292 2.767
17  1 0.403 9.407 7.900 14.481 6.200
17  2 0.419 10.769 6.361 13.192 1.944
17  3 0.325 14.480 10.135 19.640 5.000
Table 8
Network correlations period 2.
Diff DegreeCentrality Collaboration IncomeSimilarity LanguageSimilarity Diff ResearchStrength PointConnectivity GeodesicCount
Diff DegreeCentrality 1
Collaboration 0.0994 1
IncomeSimilarity 0.1053 0.1485 1
LanguageSimilarity 0.2025 0.0779 0.1147 1
Diff  ResearchStrength 0.6690 0.0386 −0.0019 0.1617 1
PointConnectivity 0.3391 0.3479 0.3127 0.1513 0.4447 1
GeodesicCount 0.2046 −0.0138 0.1560 0.0753 0.2799 0.3801 1
Table 9
Network correlations period 3.
Diff DegreeCentrality Collaboration IncomeSimilarity LanguageSimilarity Diff ResearchStrength PointConnectivity GeodesicCount
Diff DegreeCentrality 1
Collaboration 0.0943 1
IncomeSimilarity 0.0715 0.1507 1
LanguageSimilarity 0.1719 0.0579 0.1217 1
Diff ResearchStrength 0.7047 0.0502 −0.0146 0.1306 1
R
A
A
A
A
B
B
B
B
B
B
B
B
B
B
BPointConnectivity 0.2731 0.3421 0.3123 
GeodesicCount 0.2149 −0.0152 0.1530 
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